Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects
Clinical trial NCT01596712 · COMPLETED
Trial details
- NCT number
- NCT01596712
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-08-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.